PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
139.84%
Net income growth at 75-90% of CSIQ's 158.41%. Bill Ackman would call for strategic or operational tweaks to match competitor’s earnings growth.
-46.85%
Negative yoy D&A while CSIQ is 0.00%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
9.25%
Deferred tax of 9.25% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
No Data
No Data available this quarter, please select a different quarter.
-188.27%
Negative yoy working capital usage while CSIQ is 36.36%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
69.07%
AR growth of 69.07% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
-50.22%
Negative yoy inventory while CSIQ is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
283.51%
AP growth of 283.51% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
-167.20%
Negative yoy usage while CSIQ is 36.36%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
187.63%
Well above CSIQ's 126.30%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-7700.00%
Negative yoy CFO while CSIQ is 171.37%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
13.90%
Some CapEx rise while CSIQ is negative at -1.91%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
We reduce yoy other investing while CSIQ is 33.39%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
9.56%
Investing outflow well above CSIQ's 4.41%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-99.72%
Negative yoy issuance while CSIQ is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.